Corrs Chambers Westgarth
2021-09-24 6:25 pm
| Sydney
Pharmaceutical giants Merck Sharpe & Dohme and Pfizer have resolved a long-running intellectual property dispute over a 2015 patent owned by Pfizer for a pneumococcal vaccine.